Skip to main content
Fig. 1 | Clinical Epigenetics

Fig. 1

From: Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism

Fig. 1

The multi-step process of atherogenesis: Activation of the endothelium, monocyte activation and recruitment, leukocyte capture, rolling, adhesion, firm adhesion, macrophage differentiation, plaque development and stability. Apabetalone downregulates the transcription of each protein labeled in the illustration, thus impacting each step of atherogenesis. At the plaque, circulating and local cytokine expression from endothelial cells and monocytes are downregulated by apabetalone. Activation panel: pink speckles represent multiple cytokine secretion

Back to article page